General
publicado em 17/07/2013 às 11h44:00
   Dê o seu voto:

FDA aprove first medical device to help diagnose ADHD

Neuropsychiatric EEG-Based Assessment Aid (NEBA) analyzes electric impulses produced by the brain's nerve cells

 
font size
A-
A+

The first medical device designed to help medical professionals diagnose attention deficit/hyperactivity disorder (ADHD) in children and teens has been approved by the U.S. Food and Drug Administration.

The Neuropsychiatric EEG-Based Assessment Aid (NEBA) records and analyzes electric impulses produced by the brain's nerve cells, the agency said in a news release. The non-invasive device, which takes about 20 minutes to produce complete results, measures brain wave frequencies called theta and beta waves. The theta/beta ratio has been shown to be higher in young people with ADHD, the FDA said.

Citing the American Psychiatric Association, the FDA said about 9 percent of U.S. adolescents have ADHD, and the average age of diagnosis is 7 years. Children with ADHD typically have behavior problems, trouble paying attention and hyperactivity.

Device maker NEBA Health submitted data from a clinical study of 275 children and adolescents, ranging in age from 6 to 17. The study found that the new device helped professionals better diagnose children with ADHD when combined with a psychological assessment, compared to a psychological assessment alone.

Source: Food And Drug Asministration
   Palavras-chave:   NEBA    Neuropsychiatric EEG-Based Assessment Aid    Diagnose attention deficit    ADHD    FDA   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: FDA aprove first medical device to help diagnose ADHD
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: FDA aprove first medical device to help diagnose ADHD


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
NEBA    Neuropsychiatric EEG-Based Assessment Aid    diagnose attention deficit    ADHD    FDA   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.